• 1
    Jemal A, Murray R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2005;55:10-30.
  • 2
    Blot W, McLaughlin J, Winn D. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48:3282-3287.
  • 3
    American Cancer Society. Cancer Facts & Figures 2008. Atlanta, GA: American Cancer Society; 2008.
  • 4
    Hashibe M, Brennan P, Benhamou S, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. J Natl Cancer Inst. 2007;99:777-789.
  • 5
    Marron M, Boffetta P, Zhang Z. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol. 2010;39:182-196.
  • 6
    Cooley M, Wang Q, Johnson B, et al. Factors associated with smoking abstinence among smokers and recent quitters with lung and head and neck cancer. Lung Cancer. 2012;76:144-149.
  • 7
    Pinto FR, De Matos LL, Gumz Segundo W, Vanni CM, Rosa DS, Kanda JL. Tobacco and alcohol use after head and neck cancer treatment: influence of the type of oncological treatment employed. Rev Assoc Med Bras. 2011;57:168-173.
  • 8
    Potash A, Karnell L, Christensen A, Vander Weg M, Funk G. Continued alcohol use in patients with head and neck cancer. Head Neck. 2010;32:905-912.
  • 9
    Gritz ER, Demark-Wahnefried W. Health behaviors influence cancer survival. J Clin Oncol. 2009;27:1930-1932.
  • 10
    Lee P, Forey B. Misclassification of smoking habits as determined by cotinine or by repeated self-report: a summary of evidence from 42 studies. J Smoking Relat Dis. 1995;6:109-129.
  • 11
    Connor Gorber S, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 2009;11:12-24.
  • 12
    Nguyen P, Galanti L, Pirson Y, Jadoul M. Identification of current smokers among renal transplant recipients. Nephrol Dial Transplant. 2007;22:1974-1978.
  • 13
    Benowitz N. Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol. 1996;36:597-613.
  • 14
    Rubenstein M, Thompson P, Benowitz N, Shiffman F, Moscicki A. Cotinine levels in relation to smoking behavior and addiction in young adolescent smokers. Nicotine Tob Res. 2007;9:129-135.
  • 15
    Scheidweiler KB, Marrone GF, Shakleya DM, Singleton EG, Heishman SJ, Huestis MA. Oral fluid nicotine markers to assess smoking status and recency of use. Ther Drug Monit. 2011;33:609-618.
  • 16
    Marin VP, Pytynia KB, Langstein HN, Dahlstrom KR, Wei Q, Sturgis EM. Serum cotinine concentration and wound complications in head and neck reconstruction. Plast Reconstr Surg. 2008;121:451-457.
  • 17
    Warren G, Arnold S, Valentino J, et al. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population. Radiother Oncol. 2012;103:45-48.
  • 18
    Hald J, Overgaard J, Grau C. Evaluation of objective measures of smoking status: a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy. Acta Oncol. 2003;42:154-159.
  • 19
    Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11:781-789.
  • 20
    Klozar J, Tachezy R, Rotnáglová E, Koslabová E, Saláková M, Hamsíková E. Human papillomavirus in head and neck tumors: epidemiological, molecular, and clinical aspects. Wien Med Wochenschr. 2010;160:305-309.
  • 21
    Perez-Ordoñez B, Beauchemin M, Jordan RC. Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol. 2006;59:445-453.
  • 22
    Chung C, Gillison M. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res. 2009;15:6758-6762.
  • 23
    Ragin C, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121:1813-1820.
  • 24
    Kimple AJ, Torres AD, Yang RZ, Kimple RJ. HPV-associated head and neck cancer: molecular and nano-scale markers for prognosis and therapeutic stratification. Sensors. 2012;12:5159-5169.
  • 25
    Smith EM, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP. Tobacco and alcohol use increase the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes Control. 2010;21:1369-1378.
  • 26
    Schoenborn CA, Adams PE. Health behaviors of adults: United States, 2005-2007. Vital Health Stat. 2010;10:1-132.
  • 27
    Etzel R. A review of the use of saliva cotinine as a marker of tobacco-smoke exposure. Prev Med. 1990;19:190-197.
  • 28
    Lingen MW, Xiao W, Schmitt A, et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 2013;49:1-8.
  • 29
    Fu M, Martínez-Sánchez JM, Agudo A, et al; DCOT Study Investigators. Nicotine dependence and salivary cotinine concentration in daily smokers. Eur J Cancer Prev. 2012;21:96-102.
  • 30
    Fu M, Fernández E, Pascual JA, et al; DCOT Study Investigators. Stages of change, smoking characteristics, and cotinine concentrations in smokers: setting priorities for smoking cessation. Prev Med. 2011;52:139-145.
  • 31
    Tachezy R, Klozar J, Rubenstein L, et al. Demographic and risk factors in patients with head and neck tumors. J Med Virol. 2009;81:878-887.